STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] GeoVax Labs, Inc. Warrants SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Armistice Capital, LLC and Steven Boyd report beneficial ownership of 2,675,610 shares of GeoVax Labs common stock, representing 9.54% of the class. Armistice Capital is the investment manager of the direct holder (the Master Fund) and reports shared voting and dispositive power over these shares. The Master Fund disclaims beneficial ownership to the extent it lacks voting or dispositive power under its agreement with Armistice Capital.

The filing states the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. Steven Boyd, as managing member of Armistice Capital, is reported as having the same shared voting and dispositive power.

Positive
  • Material stake reported: Ownership of 2,675,610 shares equals a 9.54% position, signaling meaningful investor interest.
  • Clear governance disclosure: Armistice Capital discloses voting and dispositive authority via its role as investment manager.
Negative
  • None.

Insights

TL;DR: A hedge fund-affiliated manager reports a sizable 9.54% position with shared voting and dispositive power via a managed fund.

The position size—2,675,610 shares representing 9.54%—is material and must be monitored by investors for potential influence on governance or future actions. The filing clarifies that voting and disposition authority rests with Armistice Capital as investment manager of the Master Fund, while the Master Fund disclaims direct beneficial ownership to the extent it lacks such authority. The certification that the shares are held in the ordinary course of business and not for control limits, but does not eliminate, possible future coordination or activism.

TL;DR: Reporting shows shared voting/dispositive power through an investment manager, raising governance relevance for a sub-10% holder.

The reporting structure—Armistice Capital exercising voting and investment power on behalf of the Master Fund while the Master Fund disclaims beneficial ownership—highlights typical investment-management reporting mechanics. With nearly 10% ownership and shared voting power, the reporting persons could be influential in shareholder matters depending on other holders' dispersion. The filing’s statement that holdings are not intended to influence control is a standard disclosure but should be read alongside any future amendments or disclosures of coordination.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:08/14/2025
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:08/14/2025
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: August 14, 2025 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd

FAQ

How many GeoVax Labs (GOVXW) shares do Armistice Capital and Steven Boyd report owning?

They report beneficial ownership of 2,675,610 shares, representing 9.54% of the class.

Do Armistice Capital or Steven Boyd have sole voting power over the reported shares?

No. The filing reports 0 shares with sole voting power and 2,675,610 shares with shared voting power.

Does the Master Fund claim beneficial ownership of the shares it holds?

The Master Fund specifically disclaims beneficial ownership of the securities to the extent it lacks voting or dispositive power due to its agreement with Armistice Capital.

Were the shares acquired to change or influence control of GeoVax Labs?

The filing certifies the securities were acquired and are held in the ordinary course of business and not to change or influence control.

What authority does Armistice Capital have over the shares?

Armistice Capital, as investment manager of the Master Fund, exercises the voting and investment power over the reported securities.
Geovax Labs Inc

NASDAQ:GOVXW

GOVXW Rankings

GOVXW Latest News

GOVXW Latest SEC Filings

GOVXW Stock Data

2.35M
Biotechnology
Pharmaceutical Preparations
Link
United States
SMYRNA